tiprankstipranks
Trending News
More News >
Icon Plc (ICLR)
:ICLR
US Market
Advertisement

Icon (ICLR) Earnings Dates, Call Summary & Reports

Compare
521 Followers

Earnings Data

Report Date
Feb 25, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
3.31
Last Year’s EPS
3.43
Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view of ICON plc's performance. While there were strong business awards and strategic investments in technology, the company faced challenges with elevated cancellations and pricing pressures affecting margins. The overall outlook remains cautiously optimistic, with expectations of normalized cancellation levels and continued technological advancements.
Company Guidance
During ICON plc's Q3 2025 earnings call, the company provided guidance indicating a challenging but stable market environment. Gross business awards for the quarter were strong, totaling $3 billion, representing a mid-single-digit increase year-over-year, with significant contributions from oncology, cardiometabolic disease, and functional service provider (FSP) sectors. The company's revenue for the quarter was $2.043 billion, marking a 0.6% year-over-year increase and a 1.3% sequential rise from Q2 2025. Despite the positive revenue growth, ICON faced a flat burn rate of 8.2% and a slight decline in adjusted EBITDA margin to 19.4%, down 20 basis points sequentially, due to a higher pass-through revenue mix. The company executed $250 million in share repurchases during the quarter, contributing to a year-to-date total of $750 million. Adjusted earnings per share reached $3.31, up 1.5% from Q2, while free cash flow for the quarter was robust at $334 million. For the full year, ICON adjusted its guidance, forecasting revenue between $8.05 billion and $8.1 billion and adjusted EPS ranging from $13 to $13.20. Looking forward, ICON expects market conditions to persist similarly, with optimism for a return to normalized growth levels in 2026 as cancellations hopefully moderate and new business wins continue to strengthen.
Strong Gross Business Awards
Gross business awards totaled $3 billion, up mid-single digits year-over-year, with notable strength in oncology, cardiometabolic disease, and FSP sectors.
Share Repurchase Program
Bought back $250 million in shares during Q3, bringing total repurchases to $750 million year-to-date.
Positive Biotech Sector Performance
Significant increase in RFP flow in the biotech sector on a year-over-year and sequential basis, reflecting improved funding environment.
Revenue and Earnings Growth
Revenue increased sequentially and year-over-year, with adjusted earnings per share of $3.31, a 1.5% increase over Q2.
Strong Free Cash Flow
Generated $334 million in free cash flow during Q3 and $687 million year-to-date.
Strategic Investments in Technology
Continued focus on deploying innovative technologies, including AI-enabled tools, to enhance efficiency and predictability in clinical trials.

Icon (ICLR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ICLR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
3.31 / -
3.43
Oct 22, 2025
2025 (Q3)
3.30 / 3.31
3.35-1.19% (-0.04)
Jul 23, 2025
2025 (Q2)
3.19 / 3.26
3.75-13.07% (-0.49)
Apr 30, 2025
2025 (Q1)
3.10 / 3.19
3.47-8.07% (-0.28)
Feb 19, 2025
2024 (Q4)
3.43 / 3.43
3.46-0.87% (-0.03)
Oct 23, 2024
2024 (Q3)
3.85 / 3.35
3.31.52% (+0.05)
Jul 24, 2024
2024 (Q2)
3.68 / 3.75
3.1120.58% (+0.64)
Apr 24, 2024
2024 (Q1)
3.41 / 3.47
2.919.66% (+0.57)
Feb 21, 2024
2023 (Q4)
3.46 / 3.46
3.1310.54% (+0.33)
Oct 25, 2023
2023 (Q3)
3.27 / 3.30
310.00% (+0.30)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ICLR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 22, 2025
$192.60$180.00-6.54%
Jul 23, 2025
$167.89$195.01+16.15%
Apr 30, 2025
$151.44$145.21-4.11%
Feb 19, 2025
$191.32$201.84+5.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Icon Plc (ICLR) report earnings?
Icon Plc (ICLR) is schdueled to report earning on Feb 25, 2026, After Close (Confirmed).
    What is Icon Plc (ICLR) earnings time?
    Icon Plc (ICLR) earnings time is at Feb 25, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ICLR EPS forecast?
          ICLR EPS forecast for the fiscal quarter 2025 (Q4) is 3.31.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis